Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
Product Unit Size | Cost | Quantity | Stock |
---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
Purity | ≥95% |
---|---|
Formula | C18H25N5O5S |
Formula Wt. | 423.4 |
Synonym | MGP-pNa |
Solubility | Soluble in water. |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Found in plants in Astragalus, Allium, and Bras...
Synthesis impurity
Endogenous sulfonic acid involved in Ca2+ signa...
Triterpene aglycone found in Radix Astragali; t...
Tropane alkaloid found in plants in the Solanac...
T-type Ca2+ and voltage-gated Na+ channel block...
Camptothecin analog; topoisomerase I inhibitor,...
Vinca alkaloid found in Catharanthus; microtubu...
BHA derivative.
PKA and PDK1 inhibitor, HCN channel blocker, po...
Endogenous opioid peptide; μOR agonist.
V2 antagonist.
BRD2/4/9 and CECR2 inhibitor.
Amphiphilic properties
Synthesis impurity
HIV protease inhibitor.
Phenothiazine; D1/2 and α1-adrenergic antagoni...
Bisphosphonate.
ATP competitive CDK inhibitor.
CDK9 inhibitor.